When a patient is placed on extracorporeal membrane oxygenation (ECMO), usually emergently, families have begun to face the gravity of the situation. Suddenly, ECMO offers new hope. Even though the primary team explains ECMO will be a time-limited trial and a bridge to recovery, transplant, or device, many families remain focused only on the possibility of hope.
In the LOCO2 study, a conservative oxygen strategy with SpO2 goals of 88% to 92% was not shown to improve mortality over a liberal oxygen strategy as hypothesized, but rather was found to have a worrisome signal of increased mortality and increased mesenteric ischemia.
People with chronic obstructive pulmonary disease frequently seek care for acute exacerbations, which are associated with significant morbidity and mortality. Therefore, it is crucial for physicians to understand how to assess and treat these patients appropriately.
Acute exacerbations frequently prompt patients with chronic obstructive pulmonary disease to present to the emergency department, so it is crucial for emergency physicians to understand how to assess and treat these patients effectively.
In this group of patients hospitalized with severe COVID-19, the majority of whom required invasive ventilation, 68% showed clinical improvement after treatment with remdesivir on a compassionate-use basis.
The recommended care of a patient with COVID-19 is similar to what is required for other viral pneumonias, such as those associated with influenza or respiratory syncytial virus. Further, mild disease does not necessarily require hospitalization.
The recognition and treatment of high altitude illness is within the core content of emergency medicine practice. High altitude illness represents a spectrum of clinical entities, ranging from common and benign acute mountain sickness to life-threatening high altitude pulmonary edema and rare but potentially lethal high altitude cerebral edema.